Cleanroom Disinfectant Market

Cleanroom Disinfectant Market Outlook (2023 to 2033)

The valuation of the global cleanroom disinfectant market reached US$ 227.8 million in 2022. The market is predicted to increase to US$ 424 million by the end of 2033, advancing at a CAGR of 5.8% over the next ten years.

Mounting apprehensions regarding infection and contamination risks, especially in the research and development sectors of the pharmaceutical and biotechnology industries, have notably escalated the requirement for effective cleanroom disinfecting products. As corporations emphasize sterile environments, routine adherence to rigorous disinfection protocols, and the utilization of disinfection products have become imperative necessities.

• Oxidizing disinfectants accounted for a leading market share of 44.3% in 2022.
• Revenue from cleanroom disinfectants held 9% share of the global cleanroom equipment market in 2022.

Due to the inherent nature of their operations and the stringent quality demands, cleanrooms play a crucial role in the medical device manufacturing, biotechnology, and pharmaceutical research and development industries. These controlled environments are subject to rigorous regulations and are meticulously safeguarded against airborne particles, pollutants, and bacteria.

The maintenance of pristine and sterile processing rooms is an absolute necessity within these industries. Cleanrooms serve to avert any form of particle contamination that could compromise the functionality or safety of medical devices, culture media, and other elements, thus upholding consistent quality and dependability.

Biotechnology companies manage sensitive biological processes to produce vaccines, enzymes, and other bioproducts. Any cross-contamination can result in incorrect outcomes. Cleanrooms provide isolated settings that reduce contamination risk and ensure the integrity of biological processes.

Pharmaceutical research and development, on the other hand, deals with the discovery of new medications and therapies. The regulated environment of a cleanroom prevents external pollutants from affecting the chemical compounds being created, preventing potential negative consequences and providing correct research outcomes. Increasing number of pharmaceutical and biotechnology companies and growing research and development processes are thereby driving the consumption of cleanroom disinfectants.

Why is the use of Cleanroom Disinfectants Increasing Steadily?

“Increased Adoption of Globally Harmonized System of Classification and Labelling of Chemicals”

• Classification and usage of hazardous chemicals or materials across industries are regulated by the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) managed by the United Nations.

Cleanroom disinfectants labeled by GHS are only allowed for disinfection procedures. They help reduce bacteria and viruses, thereby protecting external pollutants from affecting the chemical compounds/research materials. End-use industries such as drug manufacturing can identify any potential worries related to particular disinfectants, thanks to widely recognized hazard icons and standardized safety data sheets provided by GHS.

It is common for cleanroom disinfectants to be used in industries with global supply chains, which simplifies the communication and understanding of chemical hazards across borders. It is also, easier for manufacturers, distributors, and end users to navigate international trade regulations and ensure the safe usage of disinfectants in cleanrooms with consistent labeling and classification.

GHS reassures customers regarding cleanroom disinfectants’ safety and effectiveness, as well as helps gain a better understanding of chemical hazards. Product safety is enhanced when disinfectant manufacturers provide comprehensive hazard information with GHS-compliant labeling, demonstrating their commitment to customer safety.

• According to a report from Health Care Without Harm (HCWH), in 2020, the Classification, Labelling, and Packaging (CLP) Regulation, aligned with the GHS, became applicable across all industries within the European Union (EU) carrying legal obligations. This regulation dictates that manufacturers, importers, or downstream users must accurately classify, label, and package hazardous chemicals before placing them on the market.

Adoption of GHS is driving the sales of cleanroom disinfectants and sterilization solutions. The GHS plays a crucial role in standardizing hazard communication, improving safety awareness, complying with regulations, facilitating global supply chains, and enhancing customer confidence, which is contributing to the demand for GHS-compliant clean room disinfectants.

Cleanroom sanitation technologies are increasingly used across various industries, including the production of oral and beta-lactam medications, powders, tablets, capsules, and intravenous drugs. Laboratory microbiology and chemical analysis also utilize cleanrooms. The pharmaceutical and related sectors must maintain strict hygiene, sterility, and contamination controls, which is a key factor driving market growth.

Can the Sales Growth of Cleanroom Disinfectant Products be Impacted in Any Way?

“Preference for More Cost-effective Alternatives Limiting Sales of Cleanroom Disinfectants”

Exploration and adoption of alternative methods or technologies such as UV-C light disinfection and other non-chemical solutions significantly impact the demand for traditional disinfectants. Alternative disinfection methods offer potential benefits that may reduce the reliance on chemical-based disinfectants as industries seek more sustainable, cost-effective, and efficient methods of maintaining contamination-free environments.

The primary advantage of alternative methods such as UV-C light disinfection is their non-toxic and environmentally friendly nature. UV-C light, devoid of chemical usage, eliminates the need to manage or dispose of potentially hazardous substances. Growing environmental consciousness has prompted both consumers and industries to pursue eco-friendly solutions.

Decreasing demand for disinfectants linked to perceived ecological damage is influenced by environmental considerations. This shift encourages the adoption of cleaner, more sustainable alternatives that align with the push for greener products and practices. The industry's adoption of these solutions is anticipated to significantly impact infection control measures and product sales over the projected period.

Country-wise Insights

Why is the United States a Leading Market for Cleanroom Disinfectants?

“Stringent Infection Control and Patient Safety Protocols for Healthcare Facilities”

The United States accounted for a leading market share of 36.1% in 2022. Cleanroom disinfectants are essential in maintaining a clean environment, preventing infections linked to healthcare, and ensuring patient safety. Hospitals, clinics, and other healthcare facilities in the country follow strict infection control protocols.

Use of cleanroom disinfectants in healthcare facilities in the United States has risen because they follow stringent infection control protocols and antimicrobial cleaners are widely used. Adherence to regulations and ensuring patient safety are central to disinfection practices in hospitals and clinics. The significance of cleanroom disinfectants has heightened as the emphasis shifts towards upholding sterile environments, thereby bolstering infection control endeavors across the healthcare sector.

Emergence of several new pharmaceutical and biotech enterprises in the United States, in addition to the existing ones, to cater to the escalating demand for innovative drugs and life science products, is also contributing to market expansion. The cleanroom disinfectant market is poised for growth in the United States over the upcoming decade.

How is the Cleanroom Disinfectant Market Shaping Up in Germany?

“High Demand for Cleanroom Disinfectants Due to Increasing Medical Device Manufacturing”

Germany accounted for a 10.7% share of the global market in 2022. Growing medical device manufacturing industry in Germany is pushing the demand for cleanroom disinfectants. Maintaining sterile conditions is essential for ensuring the safety and quality of medical devices as production facilities expand to meet the increased demand. This increase in manufacturing scale requires the use of efficient cleanroom disinfectants that successfully prevent contamination while meeting strict regulatory criteria and protecting product integrity.

Growing need to meet regulatory standards for controlled environment disinfectants to boost consumer confidence, lower the danger of contamination, and guarantee product safety is driving sales of cleanroom disinfectants in Germany.

• For instance, Sanner Group announced the expansion of its production sites in China & Germany. With this strategic action, the company is planning to increase its contract development and manufacturing activities and assembly of medical technology.

Why is China a Key Market for Cleanroom Disinfectant Manufacturers?

“Increasing Focus on Research & Development Activities”

China held 5.5% share of the global market in 2022. China was the first country to have been affected by the virus during the COVID-19 pandemic. This raised the urgency to opt for proper cleanliness and hygiene standards. Using hand sanitizers immediately became popular among the Chinese population to prevent contamination and the spread of infection.

Growing demand for vaccine development across R&D centers also necessitated the usage of hand sanitizers and other disinfectant products in China, to reduce potential contamination concerns, thus protecting research integrity and workers’ health. In China, foreign R&D center clusters supporting technological innovations are increasing in numbers.

• According to the 2023 insights from the State Council of the People's Republic of China, there are currently approximately 531 foreign-funded research and development (R&D) centers in Shanghai. Furthermore, China's investment in research and development rose from US$ 136.8 billion (CNY 1 trillion) in 2012 to US$ 410.4 billion (CNY 3 trillion) in 2022.

Category-wise Insights

Which Product is Most Widely Adopted for Disinfection Purposes?

“Efficient Microbial Killing Properties Driving Adoption of Oxidizing Disinfectants”

By product, the oxidizing disinfectant segment occupied 44.3% share of the global market in 2022. Microorganisms, including bacteria, viruses, fungi, and spores, can be efficiently eradicated using oxidizing disinfectants such as hydrogen peroxide and chlorine dioxide, known for their potent microbial-killing characteristics. Consequently, these disinfectants find utility in diverse cleanroom settings to guarantee comprehensive sterilization.

Oxidizing disinfectants are commonly utilized in cleanroom operations because of their speedy outcomes. Due to their quick action and capacity to degrade into harmless compounds while maintaining adherence to strict validation standards, these disinfectants are preferred across various industries.

Which End User Accounts for High Utilization of Cleanroom Disinfectants?

“Regulatory GMP Mandates in Pharmaceutical Sector Prompting Wide Use of Disinfectants”

By end user, pharmaceutical companies accounted for 37.9% share of the global market in 2022. The pharmaceutical industry adheres to stringent quality standards during drug manufacturing to ensure product efficacy and safety. Product contamination has the potential to compromise both the integrity and safety of drugs. Disinfectants play a crucial role in maintaining controlled sterile environments to prevent cross-contamination

Good Manufacturing Practices (GMP) are mandated by regulatory agencies like the United States Food and Drug Administration (U.S.FDA) and European Medicines Agency (EMA). As a result, cleanrooms are required to meet strict cleanliness criteria, requiring rigorous disinfection. Disinfection prevents contamination of these sensitive materials, preserving their viability. Clinical trials require a clean environment to ensure accurate results and participant safety, which again requires frequent disinfection.

Competition Landscape

To meet the evolving demands of the industry, leading players in the cleanroom disinfectant market are continually introducing innovative products. These initiatives help boost their market position, highlight technological developments, and serve sectors that need state-of-the-art products for maintaining sterile environments.

• In October 2022, Berkshire Corporation launched VersaHOCl, a powerful non-toxic low residue disinfectant. VersaHOCl is an EPA-registered one-step ready-to-use cleaner and disinfectant, with the ability to kill 99.99% of viruses, bacteria, and fungi.
• In September 2019, Steris Corporation expanded its portfolio with the launch of the Spor-Klenz read-to-use disinfectant wipes.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies manufacturing cleanroom disinfectants, which are available in the full report

Cleanroom Disinfectant Industry Report Scope

Key Segments of Cleanroom Disinfectant Industry Research

Product:

• Oxidizing Disinfectants
• Non-Oxidizing Disinfectants
• Hand Sanitizers

End-use Industry:

• Hospitals/Healthcare Facilities
• Biotechnology Industry
• Pharmaceutical Industry
• Medical Devices Industry

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

To know more about delivery timeline for this report Contact Sales